Literature DB >> 21330654

Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD.

Marianne Pons1, Maria E Marin-Castaño.   

Abstract

PURPOSE: Cigarette smoking is the strongest environmental risk factor for wet age-related macular degeneration (AMD). Inappropriate expression of proangiogenic vascular endothelial growth factor (VEGF) and antiangiogenic pigment epithelium derived factor (PEDF) may cause choroidal neovascularization (CNV), a key event in wet AMD, resulting in vision loss. Nicotine (NT), a potent angiogenic agent abundant in second-hand smoke, may play a major role in the pathogenesis of wet AMD. The purpose of this study was to evaluate the expression of nicotinic acetylcholine receptors (nAchR) in retinal pigment epithelium (RPE) and determine the effects of NT on RPE-derived VEGF and PEDF expression in the context of passive smoking.
METHODS: Human RPE cells were treated with NT (10(-8) M), with or without the nAchR-nonspecific antagonist hexamethonium (HXM) (10(-5) M) for 72 hours. RPE sheets were microdissected from rats exposed to NT in drinking water (100 μg/mL), with or without HXM (40 mg/kg/d, intraperitoneally), for 72 hours. Cell death was determined by cell count and proliferation by Western blot for proliferating cell nuclear antigen (PCNA). nAchR expression was examined by real-time PCR and Western blot. ERK activation was evaluated by Western blot analysis. VEGF and PEDF expression was assessed by ELISA, Western blot, and real-time PCR.
RESULTS: Cultured RPE cells constitutively expressed the nAchR α3, α10, and β1 subunits, with β1 being the most prevalent. The nAchR α4, α5, α7, and β2 subunits were detected in RPE sheets from rats, among which α4 is the predominant subtype. NT, which did not result in either cell death or proliferation, induced β1 nAchR, upregulated VEGF, and downregulated PEDF expression through nAChR in ARPE-19 cells. Transcriptional activation of the nAchR α4 subunit and nAChR-mediated upregulation of VEGF and PEDF were observed in RPE from rats exposed to NT.
CONCLUSIONS: NT increased the VEGF-to-PEDF ratio in the RPE through nAchR in vitro and in vivo. This alteration in the ratio may play a key role in the progression to wet AMD in passive smokers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330654      PMCID: PMC3109060          DOI: 10.1167/iovs.10-6254

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  86 in total

1.  Determination of tar, nicotine, and carbon monoxide yields in the mainstream smoke of selected international cigarettes.

Authors:  A M Calafat; G M Polzin; J Saylor; P Richter; D L Ashley; C H Watson
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

2.  Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. Research Committee on Chorioretinal Degenerations.

Authors:  A Tamakoshi; M Yuzawa; M Matsui; M Uyama; N K Fujiwara; Y Ohno
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

3.  Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro.

Authors:  A C Villablanca
Journal:  J Appl Physiol (1985)       Date:  1998-06

4.  Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo.

Authors:  Maria E Marin-Castaño; Gary E Striker; Oscar Alcazar; Paola Catanuto; Diego G Espinosa-Heidmann; Scott W Cousins
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

5.  ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons.

Authors:  Michal Toborek; Kwang Won Son; Anna Pudelko; Kelley King-Pospisil; Edward Wylegala; Andrzej Malecki
Journal:  J Cell Biochem       Date:  2007-02-01       Impact factor: 4.429

Review 6.  Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss
Journal:  Am J Epidemiol       Date:  1998-01-15       Impact factor: 4.897

7.  Nicotine: the link between cigarette smoking and the progression of renal injury?

Authors:  Edgar A Jaimes; Run-Xia Tian; Leopoldo Raij
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-08-18       Impact factor: 4.733

Review 8.  The epidemiology of age-related macular degeneration.

Authors:  Ronald Klein; Tunde Peto; Alan Bird; Mylan R Vannewkirk
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

9.  Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience.

Authors:  Milena Moretti; Silvia Vailati; Michele Zoli; Giordano Lippi; Loredana Riganti; Renato Longhi; Alessandro Viegi; Francesco Clementi; Cecilia Gotti
Journal:  Mol Pharmacol       Date:  2004-07       Impact factor: 4.436

10.  Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization.

Authors:  S C Finnemann; V L Bonilha; A D Marmorstein; E Rodriguez-Boulan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

View more
  34 in total

1.  Smoking and choroidal thickness in patients over 65 with early-atrophic age-related macular degeneration and normals.

Authors:  E J Sigler; J C Randolph; J I Calzada; S Charles
Journal:  Eye (Lond)       Date:  2014-05-16       Impact factor: 3.775

Review 2.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

3.  Nicotine increased VEGF and MMP2 levels in the rat eye and kidney.

Authors:  Mehmet Ates; Ferda Hosgorler; Oguz Yuksel; Sultan Kaya Unsal; Guven Guvendi; Asli Karakilic; Basar Koc; Sevim Kandis; Lutfiye Kanit; Nazan Uysal
Journal:  Environ Sci Pollut Res Int       Date:  2019-10-02       Impact factor: 4.223

4.  Morphologic changes in the retina after selective retina therapy.

Authors:  Ji Ho Yang; Seung-Young Yu; Tae Gi Kim; Eung Suk Kim; Hyung Woo Kwak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-18       Impact factor: 3.117

5.  Nicotine reduces VEGF-secretion and phagocytotic activity in porcine RPE.

Authors:  Alexa Karina Klettner; Johanna Doths; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-21       Impact factor: 3.117

Review 6.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

7.  The effect of nicotine on anti-vascular endothelial growth factor therapy in a mouse model of neovascular age-related macular degeneration.

Authors:  Stephen J Davis; Valeriy V Lyzogubov; Ruslana G Tytarenko; Ammar N Safar; Nalini S Bora; Puran S Bora
Journal:  Retina       Date:  2012-06       Impact factor: 4.256

Review 8.  Next-generation therapeutic solutions for age-related macular degeneration.

Authors:  Khrishen Cunnusamy; Rafael Ufret-Vincenty; Shusheng Wang
Journal:  Pharm Pat Anal       Date:  2012-05

9.  An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration.

Authors:  Daniel Wysokinski; Malgorzata Zaras; Mariola Dorecka; Maja Waszczyk; Jerzy Szaflik; Janusz Blasiak; Jacek P Szaflik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-29       Impact factor: 3.117

10.  Localization of acetylcholine-related molecules in the retina: implication of the communication from photoreceptor to retinal pigment epithelium.

Authors:  Hidetaka Matsumoto; Koji Shibasaki; Motokazu Uchigashima; Amane Koizumi; Masashi Kurachi; Yasuhiro Moriwaki; Hidemi Misawa; Koichiro Kawashima; Masahiko Watanabe; Shoji Kishi; Yasuki Ishizaki
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.